524 related articles for article (PubMed ID: 18272302)
1. Silicate release from glass for pharmaceutical preparations.
Bohrer D; Bortoluzzi F; Nascimento PC; Carvalho LM; Ramirez AG
Int J Pharm; 2008 May; 355(1-2):174-83. PubMed ID: 18272302
[TBL] [Abstract][Full Text] [Related]
2. Low availability of aluminum in formulations for parenteral nutrition containing silicate.
Bohrer D; Bortoluzzi F; do Nascimento PC; de Carvalho LM; de Oliveira SR
JPEN J Parenter Enteral Nutr; 2009; 33(6):694-701. PubMed ID: 19587384
[TBL] [Abstract][Full Text] [Related]
3. Critical evaluation of the standard hydrolytic resistance test for glasses used for containers for blood and parenteral formulations.
Bohrer D; Do Nascimento PC; Becker E; Bortoluzzi F; Depoi F; de Carvalho LM
PDA J Pharm Sci Technol; 2004; 58(2):96-105. PubMed ID: 15113075
[TBL] [Abstract][Full Text] [Related]
4. Arsenic release from glass containers by action of intravenous nutrition formulation constituents.
Bohrer D; Becker E; Nascimento PC; Mörschbächer V; de Carvalho LM; da Silva Marques M
Int J Pharm; 2006 Jun; 315(1-2):24-9. PubMed ID: 16621370
[TBL] [Abstract][Full Text] [Related]
5. Complexing Agents and pH Influence on Chemical Durability of Type I Molded Glass Containers.
Biavati A; Poncini M; Ferrarini A; Favaro N; Scarpa M; Vallotto M
PDA J Pharm Sci Technol; 2017; 71(4):306-316. PubMed ID: 28747538
[TBL] [Abstract][Full Text] [Related]
6. Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part II: amino acids for parenteral nutrition.
Bohrer D; do Nascimento PC; Binotto R; Carlesso R
J Trace Elem Med Biol; 2001; 15(2-3):103-8. PubMed ID: 11787973
[TBL] [Abstract][Full Text] [Related]
7. Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part III: Interaction container-chemicals during the heating for sterilisation.
Bohrer D; do Nascimento PC; Binotto R; Becker E
J Trace Elem Med Biol; 2003; 17(2):107-15. PubMed ID: 14531639
[TBL] [Abstract][Full Text] [Related]
8. A Contribution to an Understanding of Complexing Agents and Salt Solutions Reaction Mechanism on Chemical Attack of Type I Molded Glass Containers.
Biavati A; Severi G; Bisceglie F; Marchegiani M; Ferrarini A
PDA J Pharm Sci Technol; 2019; 73(6):538-551. PubMed ID: 31101704
[TBL] [Abstract][Full Text] [Related]
9. Calcium and phosphorus compatibility in parental nutrition solutions for neonates.
Eggert LD; Rusho WJ; MacKay MW; Chan GM
Am J Hosp Pharm; 1982 Jan; 39(1):49-53. PubMed ID: 6798868
[TBL] [Abstract][Full Text] [Related]
10. Container effects on the physicochemical properties of parenteral lipid emulsions.
Gonyon T; Carter PW; Dahlem O; Denet AR; Owen H; Trouilly JL
Nutrition; 2008; 24(11-12):1182-8. PubMed ID: 18707847
[TBL] [Abstract][Full Text] [Related]
11. Delamination propensity of pharmaceutical glass containers by accelerated testing with different extraction media.
Guadagnino E; Zuccato D
PDA J Pharm Sci Technol; 2012; 66(2):116-25. PubMed ID: 22492597
[TBL] [Abstract][Full Text] [Related]
12. Aluminum and Phthalates in Calcium Gluconate: Contribution From Glass and Plastic Packaging.
Yokel RA; Unrine JM
J Pediatr Gastroenterol Nutr; 2017 Jan; 64(1):109-114. PubMed ID: 27111341
[TBL] [Abstract][Full Text] [Related]
13. Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part I: salts, glucose, heparin and albumin.
Bohrer D; do Nascimento PC; Binotto R; Pomblum SC
J Trace Elem Med Biol; 2001; 15(2-3):95-101. PubMed ID: 11787994
[TBL] [Abstract][Full Text] [Related]
14. Physical and chemical stability of paclitaxel infusions in different container types.
Donyai P; Sewell GJ
J Oncol Pharm Pract; 2006 Dec; 12(4):211-22. PubMed ID: 17156593
[TBL] [Abstract][Full Text] [Related]
15. Particulate contamination and stability of three additives in 0.9% sodium chloride injection in plastic and glass large-volume containers.
Stokes TF; Sumner ED; Needham TE
Am J Hosp Pharm; 1975 Aug; 32(8):821-6. PubMed ID: 1146840
[TBL] [Abstract][Full Text] [Related]
16. Arsenic species in solutions for parenteral nutrition.
Bohrer D; do Nascimento PC; Becker E; de Carvalho LM; Dessuy M
JPEN J Parenter Enteral Nutr; 2005; 29(1):1-7. PubMed ID: 15715267
[TBL] [Abstract][Full Text] [Related]
17. The impact of primary packaging on the quality of parenteral products.
Solomun L; Ibric S; Boltic Z; Djuric Z; Stupar B
J Pharm Biomed Anal; 2008 Nov; 48(3):744-8. PubMed ID: 18786797
[TBL] [Abstract][Full Text] [Related]
18. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas PA; Kuzmission A; Ikeda K; Yasuo S
Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
[TBL] [Abstract][Full Text] [Related]
19. Sodium silicate as alternative to liming-reduced aluminium toxicity for Atlantic salmon (Salmo salar L.) in unstable mixing zones.
Teien HC; Kroglund F; Atland A; Rosseland BO; Salbu B
Sci Total Environ; 2006 Apr; 358(1-3):151-63. PubMed ID: 16225906
[TBL] [Abstract][Full Text] [Related]
20. Enteric-coated solid dosage forms containing sodium bicarbonate as a drug substance: an exception from the rule?
Breitkreutz J; Gan TG; Schneider B; Kalisch P
J Pharm Pharmacol; 2007 Jan; 59(1):59-65. PubMed ID: 17227621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]